Neuro Event Labs OY
About Neuro Event Labs OY
Neuro Event Labs OY is a Finnish health technology company specializing in AI-powered motion diagnostics for neurology, with a primary focus on improving the diagnosis and treatment of epilepsy. Their flagship product, Nelli®, is an AI-driven diagnostic and monitoring system that utilizes video and audio recordings to detect and characterize epileptic seizures. This non-contact solution can be deployed in both hospital and home environments, providing physicians with high-quality, objective data that complements traditional methods and addresses the inaccuracies of patient-reported seizure diaries.
Nelli® aims to revolutionize epilepsy care by offering more personalized, accurate, and scalable diagnostics. By analyzing seizure events with machine learning algorithms, the system helps clinicians with differential diagnosis, seizure classification, quantification, and assessing treatment efficacy, ultimately leading to better patient outcomes and potentially reducing the need for extensive hospital stays. The system has received CE-mark, EU MDR certification, and FDA 510(k) clearance for hospital use in the US, with commercial expansion underway in Europe and the US.
The company’s vision extends beyond epilepsy, with plans to apply their AI technology to other neurological disorders such as Parkinson’s, Sleep Apnea, and Cerebral Palsy, leveraging the data and knowledge gained in epilepsy to reduce diagnostic guesswork across a broader spectrum of conditions.
Focus Areas
Business Intelligence
| Key Investors | Hadean Ventures, SHS Capital, Maki.vc, Catalyze Capital, European Commission (EIC Accelerator), Business Finland, OmaMedical |
| Partnerships | Newcastle Royal Victoria Infirmary, Jefferson Health |
| Technology | AI-powered diagnostics, non-contact video and audio recordings, computer vision, machine learning algorithms, web-based interactive reports, cloud-based analytics |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Neuro Event Labs' Nelliu00ae system offers a transformative approach to epilepsy diagnosis and management. It provides objective, high-quality data from video and audio recordings, which significantly improves diagnostic accuracy and helps in the precise classification and quantification of seizure types. This leads to more informed treatment decisions and better assessment of treatment efficacy, ultimately increasing the chance of patients becoming seizure-free. The non-invasive, at-home monitoring capability reduces patient burden, eliminates the need for uncomfortable wearables, and can optimize the flow to Epilepsy Monitoring Units (EMUs) by providing valuable pre-screening data or reducing the need for prolonged hospital stays. The interactive reports and video playback allow for efficient review of events, saving physician time and enhancing diagnostic confidence. Furthermore, Nelliu00ae has received FDA 510(k) clearance for clinical use in US hospitals and is CE-marked, ensuring regulatory compliance and reliability.
Neuro Event Labs' Nelliu00ae system operates through a Personal Recording Unit (PRU) that captures video and audio data. This data is then securely uploaded to a cloud-based service for analysis by machine learning algorithms. Physicians access interactive reports and video footage via a web-based dashboard. While the system is largely self-contained with its own platform for data presentation, secure data transfer protocols (HIPAA and GDPR compliant) are in place. Direct integration with existing Electronic Health Record (EHR) systems would likely involve data export/import functionalities or API-based connections for seamless workflow, though the primary interface for review is their dedicated web platform.
Reviews & Opinions
Videos
News, demos, and interviews about Neuro Event Labs OY.
Videos load interactively. If none appear, search YouTube for Neuro Event Labs OY →
Press & Coverage
Frequently Asked Questions
Related Companies
Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]
SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]
Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]
EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]
Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]
Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]